GALECTIN THERAPEUTICS INC ($GALT)
Filing Information
| Accession Number | 0001133416-26-000055 |
|---|---|
| Form Type | 4 |
| Filing Date | May 28, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
1,704
Total Value
$2,459.67
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | May 26, 2026 | Exercise/Conversion | 568 | $1.23 | $698.64 | 568 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 26, 2026 | Sale | 568 | $3.10 | $1,761.03 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock option (right to buy) | Derivative | May 26, 2026 | Exercise/Conversion | 568 | $0.00 | $0.00 | 40,057 | Direct | โ | View Details |